Savaria (SIS) AI Stock Analysis

• Market Cap: C$1.83B
• Dividend Yield: 2.35%
• Average Volume (3M): 92.56K
• Price to Earnings (P/E): 23.7
• Beta (1Y): 0.80
• Revenue Growth: 3.93%
• EPS Growth: 33.44%
• Country: CA
• Employees: 2,531
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 0.37
• Shares Outstanding: 71,716,660
• 10 Day Avg. Volume: 108,400
• 30 Day Avg. Volume: 92,560
• PEG Ratio: 0.58
• Price to Book (P/B): 2.54
• Price to Sales (P/S): 1.78
• P/FCF Ratio: 14.09
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$30.40
• Price Target Upside: 19.12% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5
• EPS Forecast (FY): 1.34
• Revenue Forecast (FY): C$966.43M

• Rating: 79 Outperform
• Price Target: C$30.00 ▲(17.55% Upside)
• Action: Reiterated Date: 03/06/26
• Date: Action: Reiterated 03/06/26

The score is driven primarily by strong financial performance (cash generation and deleveraging) and a very constructive earnings call highlighting record profitability and continued margin-expansion initiatives. Technicals are supportive with a clear uptrend, while valuation is reasonable but not a standout bargain.

Positive Factors

Cash generation & deleveraging

Consistent positive operating cash flow and materially higher free cash flow through 2025 have funded meaningful debt reduction and equity strengthening, improving financial flexibility to reinvest, pursue tuck-in M&A, and sustain operations through cycles without reliance on external funding.

Savaria One operational gains

A structured continuous-improvement program (160+ initiatives) is embedding recurring operating efficiencies and margin tailwinds. Over time, these initiatives compound, raising sustainable margins and return on capital while reducing cost volatility from raw-material or labor swings.

Recurring aftermarket & diversified revenue

A mixed model of product sales plus installation and recurring aftermarket service builds a stable installed-base revenue stream. This recurring service income smooths cash flow, supports margins, and strengthens customer lock-in over multi-year replacement and maintenance cycles.

Negative Factors

Decelerating top-line growth

Top-line growth has slowed to low-single digits, signaling a maturing market position and the need for new demand drivers or successful M&A to restore faster expansion. Persistent slow growth raises dependence on margin gains and cost programs to drive earnings growth.

Europe top-line pressure

Structural headwinds in Europe—partner contract changes, prior divestments and uneven public subsidy programs—reduce predictability and market share potential. Prolonged regional weakness can cap consolidated revenue growth and require targeted repositioning or investment to regain momentum.

Lumpy patient-care demand

Reliance on large institutional projects and government funding creates variability in bookings and revenue recognition. This project-driven lumpiness complicates forecasting, can create uneven working-capital needs, and reduces the predictability of margin and cash conversion over reporting periods.

Savaria Business Overview & Revenue Model

Company Description

Savaria Corporation provides accessibility solutions for the elderly and physically challenged people in Canada, the United States, Europe, and internationally. The company operates in three segments: Accessibility, Patient Care, and Adapted Vehicles. The Accessibility segment designs, manufactures, distributes, and installs accessibility products, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair platform lifts for commercial and residential applications, and accessibility and home elevators. The Patient Care segment manufactures and distributes therapeutic support surfaces and other pressure management products for the medical and medical beds, as well as offers medical equipment and solutions for the safe handling of patients. The Adapted Vehicles segment offers distributing vehicles for people with mobility challenges for personal or commercial use. The company sells its products through dealers and by direct stores to end-user customers. Savaria Corporation was founded in 1979 and is headquartered in Laval, Canada.

How the Company Makes Money

Savaria generates revenue primarily through the sale and installation of its accessibility products such as stairlifts, home elevators, and wheelchair lifts. The company also offers maintenance and repair services for its products, providing a recurring revenue stream. Additionally, Savaria benefits from strategic partnerships with distributors and contractors, which expand its market reach and enhance sales. The growing demand for accessibility solutions, driven by an aging population and increasing awareness of mobility issues, further contributes to the company's earnings.

Savaria Financial Statement Overview

Summary

Strong fundamentals supported by consistent positive operating cash flow and higher free cash flow into 2025, meaningful deleveraging with improved equity position, and an improving profitability trend. The main offset is slowing recent revenue growth and some year-to-year free cash flow variability.

Income Statement

Revenue has grown meaningfully over the last several years (from 2020 through 2025), with growth moderating recently (2024 ~3.7% and 2025 ~2.1%). Profitability has improved versus earlier years, with net income rising from 2021 through 2025 and operating profit expanding from 2022 to 2025. That said, margins have shown some volatility historically (notably stronger net margin in 2020 vs. weaker in 2021), and recent top-line growth deceleration suggests a more mature growth phase unless new demand drivers emerge.

Balance Sheet

Leverage has improved significantly over time: total debt fell sharply into 2025 while equity increased, indicating a stronger capital structure and better financial flexibility. In 2022–2024, debt relative to equity was moderate-to-elevated but trending better, and returns on equity have been positive and improving into 2024. A watch item is that total assets were roughly stable around ~$1.1B from 2021–2025, implying growth is coming more from operating performance and mix than from balance sheet expansion.

Cash Flow

Cash generation is a clear strength: operating cash flow and free cash flow are consistently positive across the period, with free cash flow stepping up materially from 2023 to 2025. Free cash flow generally tracks earnings well (free cash flow has covered a large portion of net income in the years provided), supporting reinvestment capacity and balance sheet strengthening. The main weakness is variability in free cash flow growth year-to-year (including declines in 2021 and 2023 and a slight dip in 2025), which suggests execution and working-capital timing can swing results.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	913.53M	867.76M	836.95M	789.09M	660.98M
Gross Profit	321.22M	321.71M	286.02M	254.37M	215.54M
EBITDA	164.55M	136.58M	123.82M	114.14M	82.70M
Net Income	68.77M	48.51M	37.84M	35.31M	11.54M
Balance Sheet
Total Assets	1.10B	1.11B	1.10B	1.11B	1.11B
Cash, Cash Equivalents and Short-Term Investments	18.62M	35.24M	54.27M	45.24M	63.49M
Total Debt	205.91M	292.62M	319.38M	410.07M	432.34M
Total Liabilities	458.10M	538.94M	552.57M	656.99M	672.32M
Stockholders Equity	640.83M	575.27M	549.00M	452.97M	434.60M
Cash Flow
Free Cash Flow	115.53M	99.95M	59.76M	70.22M	41.56M
Operating Cash Flow	128.17M	120.10M	78.62M	90.74M	57.28M
Investing Cash Flow	-20.95M	-20.63M	-6.36M	-21.58M	-396.44M
Financing Cash Flow	-125.85M	-118.00M	-63.11M	-83.25M	351.80M

Savaria Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 25.52
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:SIS, the sentiment is Positive. The current price of 25.52 is above the 20-day moving average (MA) of 25.28, above the 50-day MA of 24.54, and above the 200-day MA of 21.41, indicating a bullish trend. The MACD of 0.26 indicates Positive momentum. The RSI at 54.29 is Neutral, neither overbought nor oversold. The STOCH value of 57.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:SIS.

Savaria Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SIS	79 Outperform	C$1.83B	23.68	10.22%	2.35%	3.93%	33.44%
REKO	65 Neutral	C$22.27M	15.29	3.19%	―	0.38%	―
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
VLN	47 Neutral	C$339.97M	23.33	-27.70%	3.06%	-18.71%	-845.27%

Savaria Corporate Events

Savaria Delivers Record 2025 Results and Sharply Improves Margins

Savaria reported strong results for the fourth quarter and full year 2025, driven by broad-based growth in its Accessibility and Patient Care segments and margin expansion from its two-year “Savaria One” transformation program. Revenue for 2025 rose 5.3% to $913.5 million, while adjusted EBITDA increased 15.5% to $186.3 million, lifting the adjusted EBITDA margin to 20.4% and net earnings to $68.8 million, with Q4 marking the company’s best quarter ever on several metrics including adjusted EBITDA per share.

The company also significantly strengthened its balance sheet, cutting net debt to $191.5 million and lowering its net-debt-to-adjusted-EBITDA ratio to 1.03, which management says provides ample capacity for strategic acquisitions. With hundreds of process improvement initiatives still underway, particularly after strong European accessibility growth and double-digit expansion in Patient Care, Savaria enters 2026 with improved operational efficiency, higher profitability and greater financial flexibility to pursue further growth opportunities.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$28.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Savaria Sets March 4 Release Date for Q4 2025 Results

Savaria Corporation announced it will publish its fourth-quarter 2025 financial results after markets close on March 4, 2026, followed by an investor conference call and webcast the morning of March 5. The scheduled disclosure gives investors and analysts a clear timetable for assessing the company’s recent performance and outlook, reinforcing Savaria’s communication practices as it competes in the global accessibility and medical equipment markets.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$28.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Savaria Maintains Monthly Payout With New Dividend Declaration

Savaria Corporation has declared a monthly dividend of 4.67 cents per common share, payable on March 10, 2026, to shareholders of record as of February 27, 2026. The announcement underscores the company’s continued commitment to returning capital to investors through a stable, policy-driven dividend, signalling confidence in its cash flow and ongoing operations within the accessibility and medical equipment markets.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$28.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Savaria Buys Texas Home Elevator Dealer to Boost U.S. Growth

Savaria Corporation has acquired substantially all the assets of Baxter Residential Elevators, a long-time dealer and installer of home elevators and lifts in the Dallas-Fort Worth area, which generated about US$4 million in revenue in 2025. The acquisition gives Savaria a direct foothold in the fast-growing Texas market, particularly the luxury residential segment, with BRE founder RD Baxter continuing to lead the business as a Savaria division, reinforcing continuity for customers and employees while supporting Savaria’s push to grow its home elevator market share in the region.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$28.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Savaria Maintains Payout with January Monthly Dividend Declaration

Savaria Corporation has declared a monthly dividend of 4.67 cents per common share, payable on February 10, 2026 to shareholders of record as of January 30, 2026, maintaining its regular dividend policy and signaling continued commitment to returning capital to investors. The move underscores the company’s cash-generation stability in the accessibility and medical equipment markets and is likely to be viewed positively by income-focused shareholders seeking consistent distributions from a global operator in mobility and care solutions.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$28.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Savaria to Showcase Growth Strategy at April 2026 Investor Day

Savaria Corporation will host an Investor Day in the Greater Toronto Area on April 14, 2026, featuring management presentations and a tour of its Brampton manufacturing facility. The event will provide updates on the Savaria One initiative and long-term growth plans from the company’s global leadership team, with presentation materials to be made available online afterward, underscoring Savaria’s efforts to engage investors and highlight its strategic roadmap in the accessibility and medical equipment markets.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$28.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Savaria Maintains Payout with Declaration of Monthly Dividend

Savaria Corporation, the Canadian-based accessibility solutions provider listed on the TSX, has declared a monthly dividend of 4.67 cents per common share, payable on January 9, 2026 to shareholders of record as of December 31, 2025, in line with its established dividend policy. This announcement reinforces Savaria’s ongoing commitment to returning capital to shareholders and signals continued confidence in its cash flow generation, which may be viewed positively by income-focused investors tracking the company’s performance in the global accessibility and medical equipment markets.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$24.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.